filmov
tv
Recognizing Chronic Fibrosing Interstitial Lung Disease and The Impact of COVID-19 on Clinical Care
Показать описание
This presentation provides an overview of chronic fibrosing interstitial lung diseases (ILDs), with a focus on those with progressive phenotypes. Expert faculty highlight how to recognize clinical findings of disease progression in chronic fibrosing ILDs with a progressive phenotype. Additionally, faculty review clinical characteristics and mortality in patients with COVID-19 and ILD and discuss CDC recommendations for clinical care during the COVID-19 pandemic. This presentation is sponsored by Boehringer Ingelheim Pharmaceuticals, Inc.
Speakers:
Cedric Jamie Rutland, MD
Pulmonary and Critical Care Physician
Rutland Medical Group, CEO and Medical Director Assistant Clinical Professor of Internal Medicine
UCR School of Medicine, Riverside, CA
Speakers:
Cedric Jamie Rutland, MD
Pulmonary and Critical Care Physician
Rutland Medical Group, CEO and Medical Director Assistant Clinical Professor of Internal Medicine
UCR School of Medicine, Riverside, CA
0:41:54
Recognizing Chronic Fibrosing Interstitial Lung Diseases With a Progressive Phenotype
Recognizing Chronic Fibrosing Interstitial Lung Disease and The Impact of COVID-19 on Clinical Care
0:05:20
Early Identification of Progressive Chronic Fibrosing ILD
0:04:15
Progressive Chronic Fibrosing ILD: Patient’s Perspective
0:19:42
Progressive Fibrosing Interstitial Lung Disease: Shining a Light on the Latest Clinical Advances
0:32:54
An Animated Exploration of CF-ILD: From Diagnosis to Management in the Era of Antifibrotic Therapy
0:06:36
How to Recognize and Diagnose IPF
0:01:43
Dr. Hart on Detecting and Treating Interstitial Lung Disease in HER2+ Breast Cancer
0:04:54
Diagnosis: Chronic Fibrosing ILD with Progressive Phenotype
0:52:49
Catching and Managing Progressive Fibrosing Interstitial Lung Disease Progression Earlier
0:38:19
Identifying Progressive Pulmonary Fibrosis on Imaging and Collaborating With the Multidisciplinar...
0:02:27
Detecting and Managing T-DXd–Related Interstitial Lung Disease: The Five “S” Rules
0:55:46
Virtual FTS Pediatric Session: Interstitial Lung Disease in Children
0:06:24
Chronic Fibrosing ILD: Presentation and Comorbidities
0:14:25
SSc ILD With Rapid Progression
0:33:25
The Diagnostic Process for PF Webinar
0:02:56
What is the Life Expectancy of Idiopathic Pulmonary Fibrosis?
0:07:17
Identifying Drug-Induced ILD
0:13:05
Identifying the Signs and Symptoms of PFF Case01
0:04:14
Chronic Fibrosing ILD With Progressive Phenotype Economic Burden
0:22:05
Self Care and Interstitial Lung Disease/Pulmonary Fibrosis
0:39:24
New Paradigms for Progressive Fibrosing Interstitial Lung Diseases
0:04:14
Progressive Phenotype ILD: Effect on Personal Life
0:29:51
Justin Oldham, MD MS - Interstitial Lung Disease - Educational Series
Комментарии